Drugs like Ozempic and Wegovy can have a surprising impact on the brain, suggesting potential new avenues of research and ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Weight loss is not a one-size-fits-all journey. While fad diets and trendy fitness programs might promise quick results, they ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

The acronym GLP-1 has become an increasingly popular term in the health arena, especially in the context of weight loss.

How long it takes to lose weight can vary based on a number of factors, such as age, medications you take, your activity ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Semaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis suggests a case report ...

Novo Nordisk manufactures semaglutide, which is prescribed under the brand names Ozempic (approved for diabetes) and Wegovy ...